"Fei Yan No. 1" as a Combined Treatment for COVID-19: An Efficacy and Potential Mechanistic Study
There has been a large global outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), representing a major public health issue. In China, combination therapy, including traditional Chinese medicine (TCM) as a treatment for COVID-19 has...
Saved in:
Main Authors: | Zhongzhu Ai (Author), Shanshan Zhou (Author), Weinan Li (Author), Mengfan Wang (Author), Linqun Wang (Author), Gangming Hu (Author), Ran Tao (Author), Xiaoqin Wang (Author), Yinfeng Shen (Author), Lihan Xie (Author), Yuanming Ba (Author), Hezhen Wu (Author), YanFang Yang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Deciphering the Pharmacological Mechanisms of Taohe-Chengqi Decoction Extract Against Renal Fibrosis Through Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
by: Shanshan Zhou, et al.
Published: (2020) -
Effectiveness and safety of Qingfei Dayuan granules for treating influenza and upper respiratory tract infections manifested by the pulmonary heat-toxin syndrome: A multicenter, randomized, double-blind, placebo-controlled trial
by: Weinan Li, et al.
Published: (2023) -
Fei-Yan-Qing-Hua decoction attenuates influenza virus infection by enhancing host antiviral response through microbiota-derived acetate
by: Biao Dou, et al.
Published: (2024) -
Effects of Jianpi Bushen Therapy for Treatment of CKD Anemia: A Meta-Analysis of Randomized Controlled Trials
by: Liang Li, et al.
Published: (2020) -
Mechanisms of Rostellularia procumbens (L.) Nees on treating chronic glomerulonephritis explored by network pharmacology, RNA-seq, and in vitro experiments
by: Mengfan Wang, et al.
Published: (2023)